NCT05556148View on ClinicalTrials.gov

Otrivine: Quality of Life (QoL) Impact in a Real-World Setting

PHASE4CompletedINTERVENTIONAL

Enrollment

136

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

December 20, 2022

Study Completion Date

December 20, 2022

Conditions

Common Cold

Interventions

DRUG

Otrivine Congestion Relief

0.1% Nasal Spray (Xylometazoline Hydrochloride)

Trial Locations (1)

DE11 7AQ

The VCTC, Swadlincote

All Listed Sponsors

lead

HALEON

INDUSTRY